Arthur M. Cohen & Associates’s ResMed RMD Stock Holding History

Arthur M. Cohen & Associates’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,260	Closed	-$679K	–	138
2022 Q4	$679K	Sell	3,260 -100	-3%	-$22K	0.19%	67
2022 Q3	$733K	Sell	3,360 -110	-3%	-$25K	0.2%	61
2022 Q2	$727K	Sell	3,470 -100	-3%	-$21.3K	0.18%	66
2022 Q1	$866K	Sell	3,570 -36	-1%	-$8.71K	0.18%	66
2021 Q4	$939K	Hold	3,606	–	–	0.17%	69
2021 Q3	$950K	Buy	3,606 +15	+0.4%	+$4.1K	0.19%	66
2021 Q2	$885K	Hold	3,591	–	–	0.17%	75
2021 Q1	$697K	Buy	3,591 +80	+2%	+$16K	0.16%	82
2020 Q4	$746K	Buy	3,511 +340	+11%	+$67.8K	0.18%	77
2020 Q3	$544K	Buy	+3,171	New	+$586K	0.14%	87

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arthur M. Cohen & Associates's RMD Position: Q1 2023 in Review

Arthur M. Cohen & Associates sold out of ResMed (RMD) in Q1 2023, closing a stake of 3,260 shares — an estimated $679K sold.

Arthur M. Cohen & Associates first reported a position in RMD in Q3 2020 and held it in 10 quarters. The position peaked at $950K in Q3 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

Arthur M. Cohen & Associates reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
Arthur M. Cohen & Associates sold 3,260 ResMed shares in Q1 2023, an estimated $679K.
Arthur M. Cohen & Associates first reported a position in ResMed in Q3 2020 and held it in 10 quarters.
Arthur M. Cohen & Associates's ResMed position peaked at $950K in Q3 2021.
676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2023, filed 24 Apr 2023.